https://www.macrotrends.net/stocks/charts/CRSP/crispr-therapeutics-ag/stock-splits
CRISPR Therapeutics AG - 10 Year Stock Split History | CRSP | MacroTrends
Stock split history for CRISPR Therapeutics AG since 2016. Prices shown are actual historical values and are not adjusted for either splits or dividends....
stock split historycrispr therapeuticsagyearcrsp
https://www.edgen.tech/news/post/crispr-therapeutics-misses-q1-eps-by-12-despite-partnered-drug-momentum
CRISPR Therapeutics Misses Q1 EPS by 12% Despite Partnered Drug Momentum
On May 4, 2026, CRISPR Therapeutics AG (CRSP) reported a Q1 loss of $1.28 per share, which missed the Zacks Consensus Estimate of a $1.14 loss per share.
crispr therapeuticsmissesepsdespitepartnered
https://topnewsguide.com/2026/02/23/crispr-therapeutics-nasdaq-crsp-shares-rise-despite-earnings-miss-on-pipeline-optimism/
CRISPR Therapeutics (NASDAQ: CRSP) Shares Rise Despite Earnings Miss on Pipeline Optimism - Top...
Feb 24, 2026 - Expert Analysis The recent market response to CRISPR Therapeutics (NASDAQ: CRSP) highlights the complex investor psychology surrounding biotech firms,...
crispr therapeuticsnasdaqcrspsharesrise
https://www.site24x7.com/security-reports/crispr-therapeutics
CRISPR Therapeutics AG security reports and ratings
Get free security reports and industry-wise security ratings with Digital Risk Analyzer. Assess vulnerabilities and enhance your cybersecurity strategy today!
crispr therapeuticssecurity reportsagratings
https://www.insidermonkey.com/blog/crispr-therapeutics-ag-crsp-the-biotech-stock-with-biggest-upside-potential-1425779/
CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential - Insider Monkey
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential.
crispr therapeuticsagcrspbiotechstock
https://www.pharmaceuticalonline.com/doc/cgmp-oligo-manufacturing-and-services-for-crispr-therapeutics-0001
CGMP Oligo Manufacturing And Services For CRISPR Therapeutics
Learn more about a company that has led oligonucleotide innovation with unmatched precision, quality, and CRISPR expertise to empower researchers worldwide to...
manufacturing and servicescrispr therapeuticscgmpoligo
https://www.justetf.com/uk/stock-profiles/CH0334081137
CRISPR Therapeutics Stock | CH0334081137 | A2AT0Z
What ETF is CRISPR Therapeutics in? Information about cost, fund size and performance of the ETFs that contain this stock.
crispr therapeuticsstock
https://essentialhealthcarenews.com/article/910796774-crispr-therapeutics-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference...
bank of americacrispr therapeuticsto presentglobal healthcaresecurities
https://www.fool.com/investing/2020/06/14/better-buy-crispr-therapeutics-vs-sangamo-therapeu.aspx
Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics | The Motley Fool
Jun 14, 2020 - Each company aims to use its genome editing platform to treat disease, but which has an edge?
the motley foolbetter buycrispr therapeuticsvssangamo
https://www.biospace.com/vertex-and-crispr-therapeutics-to-present-at-the-american-society-of-hematology-ash-annual-meeting-and-exposition
Vertex and CRISPR Therapeutics to Present at the American Society of Hematology (ASH) Annual...
Dec 12, 2022 - Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics announced an oral, encore presentation of clinical data from patients with sickle cell disease or...
crispr therapeuticsto presentamerican societyvertexhematology
https://research.ucc.ie/en/clippings/australia-william-marsh-rice-university-georgia-tech-research-cri-3/
Australia: William Marsh Rice University, Georgia Tech Research, CRISPR Therapeutics Receive Patent...
william marshrice universitygeorgia techcrispr therapeuticsaustralia
https://www.bigmoleculewatch.com/tag/crispr-therapeutics/
CRISPR Therapeutics
Content tagged with CRISPR Therapeutics.
crispr therapeutics
https://markets.businessinsider.com/news/stocks/crispr-therapeutics-to-participate-in-upcoming-investor-conferences-1034774948
CRISPR Therapeutics to Participate in Upcoming Investor Conferences | Markets Insider
ZUG, Switzerland and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creatin...
crispr therapeuticsinvestor conferencesmarkets insiderparticipateupcoming
https://finviz.com/news/336277/crispr-therapeutics-prices-upsized-convertible-senior-notes-offering
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Stock screener for investors and traders, financial visualizations.
crispr therapeuticspricesconvertibleseniornotes
https://roboforex.com/beginners/info/charts/stock_rst/crsp/
NASDAQ:CRSP stock price chart - CRISPR Therapeutics AG - RoboForex
Live CRSP chart and quotes. CRISPR Therapeutics AG is traded on NASDAQ. Bid 54.44 USD, ask 54.7 USD. Explore USA stocks and CFDs in 2026.
stock price chartcrispr therapeuticsnasdaqcrspag
https://allaboutbelgaum.com/news/samarth-kulkarni-belagavi-now-ceo-crispr-therapeutics/
Samarth Kulkarni From Belagavi Is Now CEO Of Crispr Therapeutics
Oct 25, 2017 - Samarth Kulkarni of Bhagya Nagar Belagavi is now the CEO of Crispr Therapeutics a biopharmaceutical company focused on developing transformative gene-based...
is nowcrispr therapeuticssamarthbelagaviceo
https://menafn.com/1110005698/CRISPR-Therapeutics-To-Participate-In-Upcoming-Investor-Conferences
CRISPR Therapeutics To Participate In Upcoming Investor Conferences
CRISPR Therapeutics To Participate In Upcoming Investor Conferences. ZUG, Switzerland and BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics...
crispr therapeuticsinvestor conferencesparticipateupcoming
https://marketinference.com/analysis/r/2026/03/11/CRSP/
Crispr Therapeutics Announces $350M Convertible Notes Offering - Market Inference
Crispr Therapeutics Announces $350M Convertible Notes Offering
crispr therapeuticsconvertible notesannouncesofferingmarket
https://futurism.com/neoscope/crispr-therapeutics-joins-hospital-for-cancer-treatment-tests
CRISPR Therapeutics Joins Hospital For Cancer Treatment Tests
CRISPR Therapeutics has teamed up with General Hospital of Massachusetts to further-widen CRISPR's near-ubiquitous applications.
for cancer treatmentcrispr therapeuticsjoinshospitaltests
https://www.reviewbrokers.net/app/ree8886b
I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations (CRSP)
Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust pipeline. Click for this CRSP update.
crispr therapeuticsbreak outexpectrevenueexceeds
https://finanza.repubblica.it/Company/Advanced?symbol=0VRQ:LN
CRISPR Therapeutics AG - Grafico Avanzato - Economia e Finanza - Repubblica.it
0VRQ:LN: andamento grafico, volume, indicatori di analisi
economia e finanzacrispr therapeuticsaggraficoavanzato
https://cleanroomtechnology.com/dps-group-expands-us-hq-after-major-projects-for-vibalogics-and-crispr-therapeutics-203672
DPS Group expands US HQ after major projects for Vibalogics and CRISPR Therapeutics
The EPCMV firm has expanded its headquarters in Massachusetts, just outside Boston, to expand its design and technical services personnel
dps groupmajor projectscrispr therapeuticsexpandsus
https://synapse.patsnap.com/organization/5bd2e5325df0c48d5191d96389b4b30b
CRISPR Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore CRISPR Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 126 news, and 7 literature, Disease Domain:Neoplasms,...
crispr therapeuticsdrug pipelinesclinical trialsincpatents
https://interviewsolver.com/interview-questions/crispr-therapeutics
Crispr Therapeutics Interview Questions | Interview Solver | AI Copilot for coding interviews
May 13, 2026 - Practice 49 Crispr Therapeutics coding interview questions. 10 Easy, 31 Medium, 8 Hard problems.
crispr therapeuticsinterview questionsai copilotcoding interviewssolver
https://www.home.saxo/cs-cz/markets/stocks/crsp-xnas
CRISPR Therapeutics Ltd akcie | Saxo Bank
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics.
crispr therapeuticssaxo bankltdakcie
https://www.advancingrna.com/doc/from-supporting-component-to-strategic-driver-the-evolving-role-of-grna-in-crispr-therapeutics-0001
From Supporting Component to Strategic Driver The Evolving Role of gRNA in CRISPR Therapeutics
Guide RNA is evolving from a simple targeting reagent into a complex, engineered molecule shaped by expanding CRISPR modalities, increasing length and...
role ofcrispr therapeuticssupportingcomponentstrategic
https://www.davispolk.com/experience/crispr-therapeutics-600-million-convertible-notes-offering
CRISPR Therapeutics $600 million convertible notes offering | Davis Polk
Davis Polk acted as special product counsel to the initial purchasers in a Rule 144A offering by CRISPR Therapeutics AG of $600 million aggregate principal...
crispr therapeuticsconvertible notesdavis polkmillionoffering
https://bioscience.lonza.com/lonza_bs/CH/en/webinar-crispr-cas-9-cell-therapeutics---the-next-generation-of-cures
CRISPR/Cas 9 cell therapeutics | Lonza
View our webinar on strategies for using CRIPSR/Cas 9 for curing genetic diseases and the impact on next generation disease model systems and drug screening.
crisprcascelltherapeuticslonza
https://aqmen365.com/tides/crispr/
CRISPR | TIDES USA: Oligonucleotide & Peptide Therapeutics
crisprtidesusapeptidetherapeutics
https://cris.biu.ac.il/en/publications/off-target-effects-in-crispr-cas-genome-editing-for-human-therape/
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges -...
off targetgenome editingeffectscrisprcas